 |
|
|
| |
Elvitegravir (EVG)/Cobicistat (COBI)/Emtricitabine (FTC)/Tenofovir Disoproxil Fumarate (TDF) Is Superior to Ritonavir (RTV)-Boosted Atazanavir (ATV) Plus FTC/TDF in Treatment-Naïve Women With HIV-1 Infection (WAVES Study)
|
| |
| |
Reported by Jules Levin
ICAAC 2015 Sept 17-21 2015 San Diego, CA
Sally Hodder,1 Kathleen Squires,2 Joseph Gathe,3 Cissy Kityo,4 Kuanchai Supparatpinyo,5 Grigory Moshkovich,6 Monica Thorman,7 Margaret Johnson,8 Lisa Montafia,9 Shuping Jiang,9 Kirsten White,9 Javier Szwarcberg,9 Huyen Cao9
1West Virginia University, Morgantown, WV; 2Thomas Jefferson University Hospital, Philadelphia, PA; 3Therapeutic Concepts, Houston, TX; 4Joint Clinical Research Centre, Kampala, Uganda; 5Thai Research Institute for Health Sciences, Chiang Mai, Thailand; 6Nizhny Novgorod Regional Center AIDS, Nizhny Novgorod, Russian Federation; 7Salvador Gautier Hospital, Santo Domingo, Dominican Republic; 8Royal Free Hospital, Hampstead, UK; 9Gilead Sciences, Inc., Foster City, CA
|
| |
|
|
|
|
|
